Biomerica (BMRA) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart

Biomerica Revenue Highlights

Latest Revenue (Q)

$1.81M

Main Segment (Y)

ClinicalLabMember

Main Geography (Y)

ClinicalLabMember

Biomerica Revenue by Period

Biomerica Revenue by Year

Date	Revenue	Change
2024-05-31	-	-100.00%
2023-05-31	$5.34M	-71.71%
2022-05-31	$18.87M	162.14%
2021-05-31	$7.20M	7.57%
2020-05-31	$6.69M	28.69%
2019-05-31	$5.20M	-6.53%
2018-05-31	$5.56M	-3.93%
2017-05-31	$5.79M	12.68%
2016-05-31	$5.14M	3.58%
2015-05-31	$4.96M	-3.09%
2014-05-31	$5.12M	-20.89%
2013-05-31	$6.47M	6.44%
2012-05-31	$6.08M	24.12%
2011-07-29	$4.90M	-3.46%
2010-05-31	$5.08M	2.85%
2009-05-31	$4.93M	0.17%
2008-05-31	$4.93M	-14.30%
2007-05-31	$5.75M	-20.00%
2006-05-31	$7.18M	-22.53%
2005-05-31	$9.27M	1.15%
2004-05-31	$9.17M	1.20%
2003-05-31	$9.06M	5.37%
2002-05-31	$8.60M	-3.82%
2001-05-31	$8.94M	11.28%
2000-05-31	$8.03M	-7.66%
1999-05-31	$8.70M	-7.45%
1998-05-31	$9.40M	2.17%
1997-05-31	$9.20M	-3.16%
1996-05-31	$9.50M	3.26%
1995-05-31	$9.20M	10.84%
1994-05-31	$8.30M	3.75%
1993-05-31	$8.00M	-

Biomerica generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Biomerica Revenue by Quarter

Date	Revenue	Change
2024-08-31	$1.81M	61.92%
2024-05-31	$1.12M	9.73%
2024-02-29	$1.02M	-35.10%
2023-11-30	$1.57M	-8.52%
2023-08-31	$1.71M	54.57%
2023-05-31	$1.11M	-0.29%
2023-02-28	$1.11M	-25.00%
2022-11-30	$1.48M	-9.50%
2022-08-31	$1.64M	-69.12%
2022-05-31	$5.30M	-30.78%
2022-02-28	$7.66M	64.85%
2021-11-30	$4.65M	268.28%
2021-08-31	$1.26M	19.71%
2021-05-31	$1.05M	-70.95%
2021-02-28	$3.63M	164.38%
2020-11-30	$1.37M	20.00%
2020-08-31	$1.14M	-58.03%
2020-05-31	$2.72M	131.54%
2020-02-29	$1.18M	-26.28%
2019-11-30	$1.60M	33.66%
2019-08-31	$1.19M	2.45%
2019-05-31	$1.17M	-7.56%
2019-02-28	$1.26M	-15.97%
2018-11-30	$1.50M	17.91%
2018-08-31	$1.27M	12.60%
2018-05-31	$1.13M	-17.83%
2018-02-28	$1.38M	-14.75%
2017-11-30	$1.61M	11.71%
2017-08-31	$1.44M	-0.34%
2017-05-31	$1.45M	-3.37%
2017-02-28	$1.50M	4.73%
2016-11-30	$1.43M	1.57%
2016-08-31	$1.41M	6.33%
2016-05-31	$1.33M	-2.61%
2016-02-29	$1.36M	16.87%
2015-11-30	$1.17M	-9.47%
2015-08-31	$1.29M	-13.91%
2015-05-31	$1.49M	15.05%
2015-02-28	$1.30M	14.63%
2014-11-30	$1.13M	9.58%
2014-08-31	$1.03M	-38.39%
2014-05-31	$1.68M	12.49%
2014-02-28	$1.49M	59.68%
2013-11-30	$934.84K	-7.78%
2013-08-31	$1.01M	-31.06%
2013-05-31	$1.47M	3.80%
2013-02-28	$1.42M	-24.79%
2012-11-30	$1.88M	10.68%
2012-08-31	$1.70M	10.36%
2012-05-31	$1.54M	1.82%
2012-02-29	$1.51M	-6.31%
2011-11-30	$1.62M	14.84%
2011-08-31	$1.41M	15.86%
2011-05-31	$1.21M	-9.73%
2011-02-28	$1.35M	15.94%
2010-11-30	$1.16M	-1.43%
2010-08-31	$1.18M	-15.71%
2010-05-31	$1.40M	-2.28%
2010-02-28	$1.43M	29.98%
2009-11-30	$1.10M	-4.24%
2009-08-31	$1.15M	-7.84%
2009-05-31	$1.25M	-9.27%
2009-02-28	$1.37M	22.58%
2008-11-30	$1.12M	-6.18%
2008-08-31	$1.19M	-9.39%
2008-05-31	$1.32M	6.23%
2008-02-29	$1.24M	-

Biomerica generated $1.81M in revenue during Q1 2025, up 61.92% compared to the previous quarter, and up 163.06% compared to the same period a year ago.

Biomerica Revenue Breakdown

Biomerica Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	May 21	May 20
PhysiciansOfficeMember	$2.80M	$2.19M
LabSuppliesMember	$3.00K	-
ClinicalLabMember	$3.08M	$2.92M
ContractManufacturingMember	$552.00K	$305.76K
OverthecounterMember	$766.00K	-
OTCMember	-	$1.27M

Biomerica's latest annual revenue breakdown by segment (product or service), as of May 21: ClinicalLabMember (42.74%), PhysiciansOfficeMember (38.91%), OverthecounterMember (10.64%), ContractManufacturingMember (7.67%), and LabSuppliesMember (0.04%).

Quarterly Revenue by Product

Product/Service	Feb 24	Nov 23	Feb 22	Nov 21	Aug 21	May 21	Feb 21	Nov 20	Aug 20	May 20	Feb 20
Physician's Office	$3.00K	$1.00K	-	-	-	-	-	-	-	-	-
Clinical Lab	$404.00K	$992.00K	$723.00K	-	-	-	-	-	-	-	-
Contract Manufacturing	$281.00K	$131.00K	$151.00K	-	-	-	-	-	-	-	-
PhysiciansOfficeMember	-	-	$6.52M	$3.36M	$257.00K	$66.00K	$2.38M	$153.27K	$197.33K	$2.04M	-
ClinicalLabMember	-	-	$731.00K	$642.00K	$886.00K	$636.00K	$967.00K	$892.80K	$581.71K	$153.43K	-
ContractManufacturingMember	-	-	$167.00K	$112.00K	$40.00K	$191.00K	$130.00K	$51.34K	$179.86K	$41.76K	-
OverthecounterMember	-	-	$244.00K	$534.00K	$79.00K	-	-	-	-	-	-
LabSuppliesMember	-	-	-	-	-	-	$116.00	$2.88K	-	-	-
OTCMember	-	-	-	-	-	-	$148.00K	$272.22K	$184.91K	$491.54K	-
Physicians Office	-	-	-	-	-	-	-	-	-	-	$32.00K
OTC	-	-	-	-	-	-	-	-	-	-	$271.00K

Biomerica's latest quarterly revenue breakdown by segment (product or service), as of Feb 24: Clinical Lab (58.72%), Contract Manufacturing (40.84%), and Physician's Office (0.44%).

Biomerica Revenue Breakdown by Country

Annual Revenue by Country

Country	May 21	May 20
ClinicalLabMember	$3.08M	$2.92M
PhysiciansOfficeMember	$2.80M	$2.19M
OverthecounterMember	$766.00K	-
LabSuppliesMember	$3.00K	-
ContractManufacturingMember	$552.00K	$305.76K
OTCMember	-	$1.27M

Biomerica's latest annual revenue breakdown by geography, as of May 21: ClinicalLabMember (42.74%), PhysiciansOfficeMember (38.91%), OverthecounterMember (10.64%), ContractManufacturingMember (7.67%), and LabSuppliesMember (0.04%).

Quarterly Revenue by Country

Country	Feb 23	Feb 22
Europe	$301.00K	-
South America	$5.00K	-
Asia	$345.00K	-
North America	$461.00K	-
PhysiciansOfficeMember	-	$6.52M
OverthecounterMember	-	$244.00K
ContractManufacturingMember	-	$167.00K
ClinicalLabMember	-	$731.00K

Biomerica's latest quarterly revenue breakdown by geography, as of Feb 23: North America (41.46%), Asia (31.03%), Europe (27.07%), and South America (0.45%).

Biomerica Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SRDX	Surmodics	$126.08M	$30.34M
SGHT	Sight Sciences	$81.06M	$20.16M
NPCE	NeuroPace	$65.42M	$21.06M
SSKN	STRATA Skin Sciences	$33.36M	$8.44M
TNON	Tenon Medical	$2.93M	$887.00K
TIVC	Tivic Health Systems	$1.18M	$126.00K
AIMD	Ainos	$122.11K	-
NXL	Nexalin	$110.75K	$36.03K
MODD	Modular Medical	-	-
MOVE	Movano	-	$50.00K
BBLG	Bone Biologics	-	-
BMRA	Biomerica	-	$1.81M

BMRA Revenue FAQ

What is Biomerica’s yearly revenue?

Biomerica's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $5.34M, representing a decrease of -71.71% compared to 2022. BMRA's yearly revenue for 2022 was $18.87M, representing an increase of 162.14% compared to 2021.

What is Biomerica’s quarterly revenue?

Biomerica's quarterly revenue for Q1 2025 was $1.81M, a 61.92% increase from the previous quarter (Q4 2024), and a 5.49% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.12M, a 9.73% increase from the previous quarter (Q3 2024), and a 0.70% increase year-over-year (Q4 2023). BMRA's quarterly revenue for Q3 2024 was $1.02M, a -35.10% decrease from the previous quarter (Q2 2024), and a -8.50% decrease year-over-year (Q3 2023).

What is Biomerica’s revenue growth rate?

Biomerica's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Biomerica’s revenue streams?

Biomerica's revenue streams in y 21 are PhysiciansOfficeMember, LabSuppliesMember, ClinicalLabMember, ContractManufacturingMember, and OverthecounterMember. PhysiciansOfficeMember generated $2.8M in revenue, accounting 38.91% of the company's total revenue, up 27.61% year-over-year. LabSuppliesMember generated $3K in revenue, accounting 0.04% of the company's total revenue ClinicalLabMember generated $3.08M in revenue, accounting 42.74% of the company's total revenue, up 5.29% year-over-year. ContractManufacturingMember generated $552K in revenue, accounting 7.67% of the company's total revenue, up 80.53% year-over-year. OverthecounterMember generated $766K in revenue, accounting 10.64% of the company's total revenue

What is Biomerica’s main source of revenue?

For the fiscal year ending May 21, the largest source of revenue of Biomerica was ClinicalLabMember. This segment made a revenue of $3.08M, representing 42.74% of the company's total revenue.